Market Tracker

02/12 5:16pm ET

Nymox Pharmaceutical Corp (NASDAQ:NYMX)

2.15
Delayed Data
As of Feb 12
 -0.02 / -0.92%
Today’s Change
0.36
Today|||52-Week Range
4.37
-34.45%
Year-to-Date
No recent news for Nymox Pharmaceutical Corp.

Today’s Trading

Previous close2.17
Today’s open2.17
Day’s range2.09 - 2.22
Volume100,116
Average volume (3 months)295,090
Market cap$91.9M
Dividend yield--
Data as of 4:00pm ET, 02/12/2016

Growth & Valuation

Earnings growth (last year)+7.14%
Earnings growth (this year)--
Earnings growth (next 5 years)--
Revenue growth (last year)-12.19%
P/E ratioNM
Price/Sales4.78
Price/Book--

Competitors

 Today’s
change
Today’s
% change
XOMAXOMA Corp+0.01+0.74%
OHRPOHR Pharmaceutical I...+0.07+2.42%
MRNSMarinus Pharmaceutic...+0.29+6.40%
PRQRProQR Therapeutics N...-0.02-0.51%
Data as of 4:00pm ET, 02/12/2016

Financials

Next reporting dateMarch 11, 2016
EPS forecast (this quarter)-$0.11
Annual revenue (last year)$2.9M
Annual profit (last year)-$4.6M
Net profit margin-155.76%

Profile

Sector
Health Technology
Industry
Medical Specialties
Chairman, President &
Chief Executive Officer
Paul Averback
Chief Financial Officer
Erik Danielsen
Corporate headquarters
Saint-Laurent, Quă©bec

Forecasts